Pegylated IGF-1 splice variant peptide (research-stage)
Pegylated Mechano Growth Factor
A pegylated muscle-repair peptide theorized to promote localized regeneration; human evidence is preclinical or anecdotal.
- Evidence:
- Preclinical evidence primarily
- Status:
- Research-stage
- Reviewed:
- 2026-08-03
Also known as: Pegylated Mechano Growth Factor
What is Pegylated Mechano Growth Factor?
A pegylated muscle-repair peptide theorized to promote localized regeneration; human evidence is preclinical or anecdotal.
This profile is educational. It organizes publicly discussed research context for Pegylated Mechano Growth Factor and related naming aliases — it is not a treatment guide.
Proposed mechanism
IGF-1Ec splice variant (MGF) proposed to activate satellite cells and local muscle repair; pegylation extends half-life.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Preclinical evidence primarily
Preclinical evidence grade: Early-stage human research
Mechano growth factor is an IGF-1 splice variant upregulated after mechanical load. PEG-MGF is a research peptide without clinical trials. Preclinical muscle repair data exist. Human evidence remains insufficient. WADA prohibits IGF-1 related agents.
Key uncertainties
- Local vs systemic effects in humans
- Safety of IGF-1 pathway modulation
Research areas being studied
- Muscle repair
- Satellite cell biology
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Not systematically characterized in humans
Additional risks & considerations
- Unproven human efficacy
- IGF-1 pathway theoretical risks
- WADA prohibited
Regulatory status
Research-stage
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is Pegylated Mechano Growth Factor?
A pegylated muscle-repair peptide theorized to promote localized regeneration; human evidence is preclinical or anecdotal.
How does Pegylated Mechano Growth Factor work (proposed mechanism)?
IGF-1Ec splice variant (MGF) proposed to activate satellite cells and local muscle repair; pegylation extends half-life.
What is Pegylated Mechano Growth Factor being researched for?
Pegylated Mechano Growth Factor has been discussed in research contexts including: Muscle repair, Satellite cell biology.
What does current evidence say about Pegylated Mechano Growth Factor?
Preclinical evidence primarily. Mechano growth factor is an IGF-1 splice variant upregulated after mechanical load. PEG-MGF is a research peptide without clinical trials. Preclinical muscle repair data exist. Human evidence remains insufficient. WADA prohibits IGF-1 related agents.
What safety considerations are noted for Pegylated Mechano Growth Factor?
Reported or discussed considerations include: Not systematically characterized in humans; Unproven human efficacy; IGF-1 pathway theoretical risks; WADA prohibited. This is educational information, not medical advice.
References & sources
- Hill M et al. (2003). Mechano-growth factor: a local growth factor in skeletal muscle — J Physiol. Evidence type: animal.
Prefer interactive tools? Open the PepGuide library entry for Pegylated Mechano Growth Factor or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.